Fabarta Co., Ltd., a leading provider of enterprise-grade AI agents and knowledge engines, today announced a major strategic upgrade to its ...

Cathie Wood’s Ark Invest increased its exposure to AI infrastructure, digital platforms, and biotechnology, led by purchases ...

Lawrence Lessig and Yoshua Bengio suggest how to reduce serious risks without abandoning American technological leadership.

Google open-sourced Harness2, a recursive agent harnessing framework that lifted GLM-5 11.5 points on WorkBuddy-Bench with ...

Anthropic co-founder Jack Clark moved his recursive self-improvement forecast from late 2028 to 2027, citing Claude's growing ...

Anthropic’s Jack Clark now favors 2027 for AI to fully improve itself, citing gains in research judgment that could speed up ...

Recursion Pharma launches a $200M equity offering and reports a Sanofi milestone but is rated a Hold on limited near-term ...

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) snapped a three-day winning streak on Thursday, surging as much as 17.9 percent ...

Recursion Pharmaceuticals Inc. announced Thursday that Sanofi has selected the first development candidate under their research collaboration, triggering a $10 million milestone p ...

Recursion (RXRX) stock dips after $200M equity offering despite Sanofi (SNY) choosing its first AI drug candidate under a ...

Prices displayed are informational. Learn more Recursion Pharmaceuticals (RXRX) said Thursday it priced an offering of 61.5 million shares at $3.25 each to raise gross proceeds of about $200 million.